Ketamine enhances structural plasticity in human dopaminergic neurons:possible relevance for treatment-resistant depression

被引：3
|
作者：
Ginetta Collo [1 ,2 ]
Emilio Merlo Pich [3 ,4 ]
机构：
[1] Department of Molecular and Translational Medicine,Section of Pharmacology,University of Brescia
[2] Department of Biomedicine,University of Basel
[3] Neuroscience Therapeutic Area Unit,Takeda Pharmaceuticals International
来源：
Neural Regeneration Research | 2018年 / 13卷 / 04期
关键词：
MEK; ERK; Ketamine enhances structural plasticity in human dopaminergic neurons:possible relevance for treatment-resistant depression; TRD; MDD;
D O I：
暂无
中图分类号：
R749.4 [情感性精神病];
学科分类号：
100205 ;
摘要：
Depression refers to a series of mental health issues characterized by loss of interest and enjoyment in everyday life,low mood and selected emotional,cognitive,physical and behavioral symptoms.Depression is a common disorder,affecting 5–15%of the general population.When diagnosed as major depressive disorder(MDD),patients are currently
引用
收藏
页码：645 / 646
页数：2
相关论文
共 50 条
  • [11] Feasibility of continuation ketamine for treatment-resistant depression
    aan het Rot, Marije
    Mathew, Sanjay J.
    Collins, Katherine A.
    Perez, Andrew M.
    Murrough, James W.
    Reich, David L.
    Charney, Dennis S.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 220S - 220S
  • [12] Ketamine in Late Life Treatment-Resistant Depression
    Heard, Erika
    Sohail, Yousuf
    Nagar, Anusuiya
    Glass, Oliver M.
    Hermida, Adriana P.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2017, 25 (03): : S66 - S66
  • [13] Maintenance Ketamine Therapy for Treatment-Resistant Depression
    Archer, Shaina
    Chrenek, Carson
    Swainson, Jennifer
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (04) : 380 - 384
  • [14] The role of intranasal ketamine in treatment-resistant depression
    Costa, M.
    Fraga, M.
    Moutinho, A.
    Cintra, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S492 - S492
  • [15] INTRAVENOUS KETAMINE FOR TREATMENT-RESISTANT DEPRESSION IN ADOLESCENTS?
    Cullen, Kathryn R.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10): : S284 - S284
  • [16] Magnesium in Ketamine Administration in Treatment-Resistant Depression
    Gorska, Natalia
    Cubala, Wieslaw Jerzy
    Slupski, Jakub
    Wiglusz, Mariusz Stanislaw
    Galuszko-Wegielnik, Maria
    Kawka, Mateusz
    Grzegorzewska, Agata
    PHARMACEUTICALS, 2021, 14 (05)
  • [17] KETAMINE FOR TREATMENT-RESISTANT DEPRESSION: A NEW ADVOCATE
    Perez-Esparza, Rodrigo
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2018, 70 (02): : 65 - 67
  • [18] Clinical Efficacy of Ketamine for Treatment-resistant Depression
    Bratsos, Sosipatros
    Saleh, Sohag N.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (07)
  • [19] Oral ketamine for the treatment of pain and treatment-resistant depression
    Schoevers, Robert A.
    Chaves, Tharcila V.
    Balukova, Sonya M.
    aan het Rot, Marije
    Kortekaas, Rudie
    BRITISH JOURNAL OF PSYCHIATRY, 2016, 208 (02) : 108 - 113
  • [20] Copper Concentrations in Ketamine Therapy for Treatment-Resistant Depression
    Slupski, Jakub
    Cubala, Wieslaw Jerzy
    Gorska, Natalia
    Slupska, Anita
    Galuszko-Wegielnik, Maria
    BRAIN SCIENCES, 2020, 10 (12) : 1 - 9
12345